Plavix generic makers agonize over market entry

Published: 2008-02-04 06:58:00

Updated: 2008-02-04 06:58:00

Korea's 17 generic makers won the right to market Plavix (clopidogrel bisulfate) in a recent patent lawsuit, several drug makers who will join the lucrative market with their newly modified medicines are keen on the listing of the national health insurance.

Last October, Chong Kun Dang's Prigr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK